1. Home
  2. KSPI vs ROIV Comparison

KSPI vs ROIV Comparison

Compare KSPI & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KSPI
  • ROIV
  • Stock Information
  • Founded
  • KSPI 2008
  • ROIV 2014
  • Country
  • KSPI Kazakhstan
  • ROIV United Kingdom
  • Employees
  • KSPI N/A
  • ROIV N/A
  • Industry
  • KSPI
  • ROIV Biotechnology: Pharmaceutical Preparations
  • Sector
  • KSPI
  • ROIV Health Care
  • Exchange
  • KSPI Nasdaq
  • ROIV Nasdaq
  • Market Cap
  • KSPI 13.6B
  • ROIV 14.1B
  • IPO Year
  • KSPI 2024
  • ROIV N/A
  • Fundamental
  • Price
  • KSPI $74.50
  • ROIV $20.93
  • Analyst Decision
  • KSPI Buy
  • ROIV Strong Buy
  • Analyst Count
  • KSPI 2
  • ROIV 8
  • Target Price
  • KSPI $113.00
  • ROIV $21.19
  • AVG Volume (30 Days)
  • KSPI 565.6K
  • ROIV 8.3M
  • Earning Date
  • KSPI 11-10-2025
  • ROIV 11-10-2025
  • Dividend Yield
  • KSPI N/A
  • ROIV N/A
  • EPS Growth
  • KSPI 13.36
  • ROIV N/A
  • EPS
  • KSPI 10.48
  • ROIV N/A
  • Revenue
  • KSPI $6,665,289,776.00
  • ROIV $20,329,000.00
  • Revenue This Year
  • KSPI $37.63
  • ROIV N/A
  • Revenue Next Year
  • KSPI $21.15
  • ROIV $320.50
  • P/E Ratio
  • KSPI $7.06
  • ROIV N/A
  • Revenue Growth
  • KSPI 54.22
  • ROIV N/A
  • 52 Week Low
  • KSPI $70.61
  • ROIV $8.73
  • 52 Week High
  • KSPI $113.55
  • ROIV $21.35
  • Technical
  • Relative Strength Index (RSI)
  • KSPI 50.79
  • ROIV 68.45
  • Support Level
  • KSPI $70.63
  • ROIV $19.99
  • Resistance Level
  • KSPI $74.66
  • ROIV $20.99
  • Average True Range (ATR)
  • KSPI 2.15
  • ROIV 0.72
  • MACD
  • KSPI 0.32
  • ROIV -0.16
  • Stochastic Oscillator
  • KSPI 59.94
  • ROIV 69.87

About KSPI Joint Stock Company Kaspi.kz

Kaspi.kz JSC is the payment, marketplace, and Fintech ecosystem in Kazakhstan. The firm provides interconnected technologically seamless products and services that help people to pay, shop and manage their finances. Its operating segment includes the Payments Platform that connects its customers, which consist of both consumers and merchants, to facilitate cashless, digital transactions, the Marketplace Platform that connects merchants and consumers enabling merchants to increase their sales and consumers to buy a broad selection of products and services offered by a variety of merchants, and Fintech Platform that enables customers to manage their personal finances online and access consumer finance and deposit products through the Kaspi.kz Super App.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: